The first installment of our new predictive index shows that dealmakers expect overall M&A to increase, with health care outperforming the overall market READ MORE 


ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld


GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market


Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
TPG Backs Team to Take ShangPharma Private

The deal is being facilitated through the San Francisco firm's life science unit TPG Biotech

Private equity firm TPG Capital backed a consortium of buyers as part of a deal that would see ShangPharma Corp. (NYSE: SHP) be taken private for $173 million.

Through its life science venture investment arm TPG Biotech, the San Francisco firm has teamed with ChemExplorer Investment Holdings Ltd., ChemPartner Investment Holdings Ltd., Joint Benefit Group Ltd. and Han Ming Tech Investment Ltd. to purchase ShangPharma for 50 cents per share.

The offer represents a 30.8 percent premium over the closing price of $6.88 per share on July 5, the last trading day prior to the Shanghai company's announcement that it had received a "going private" proposal.

Investment adviser J.P. Morgan Securities (Asia Pacific) Ltd. managed the assignment, while O'Melveny and Myers LLP and Ropes & Gray LLP served as U.S. legal advisers.

Skadden Arps Slate Meagher & Flom LLP handled legal matters for the target.


For more information on related topics, visit the following: